These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2003275)
1. Evaluation of compounds as barriers to dermal penetration of organophosphates using acetylcholinesterase inhibition. Olson CT; Feder PI; Hobson DW; Kiser RC; Joiner RL Toxicol Lett; 1991 Mar; 55(3):325-34. PubMed ID: 2003275 [TBL] [Abstract][Full Text] [Related]
2. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Worek F; Reiter G; Eyer P; Szinicz L Arch Toxicol; 2002 Sep; 76(9):523-9. PubMed ID: 12242610 [TBL] [Abstract][Full Text] [Related]
3. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069 [TBL] [Abstract][Full Text] [Related]
4. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model. Ashani Y; Pistinner S Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276 [TBL] [Abstract][Full Text] [Related]
5. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study. Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253 [TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds? Maxwell DM; Brecht KM; Koplovitz I; Sweeney RE Arch Toxicol; 2006 Nov; 80(11):756-60. PubMed ID: 16770629 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro. Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626 [TBL] [Abstract][Full Text] [Related]
8. Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring. Yuknavage KL; Fenske RA; Kalman DA; Keifer MC; Furlong CE J Toxicol Environ Health; 1997 May; 51(1):35-55. PubMed ID: 9169060 [TBL] [Abstract][Full Text] [Related]
9. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro. Horn G; de Koning MC; van Grol M; Thiermann H; Worek F Toxicol Lett; 2018 Dec; 299():218-225. PubMed ID: 30312685 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a substituted β-cyclodextrin to prevent cyclosarin toxicity in vivo. Worek F; Seeger T; Zengerle M; Kubik S; Thiermann H; Wille T Toxicol Lett; 2014 Apr; 226(2):222-7. PubMed ID: 24561299 [TBL] [Abstract][Full Text] [Related]
11. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes. Worek F; Wille T; Koller M; Thiermann H Chem Biol Interact; 2013 Mar; 203(1):125-8. PubMed ID: 22827894 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose. Shih TM; Skovira JW; O'Donnell JC; McDonough JH Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239 [TBL] [Abstract][Full Text] [Related]
13. Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase. Worek F; Aurbek N; Wetherell J; Pearce P; Mann T; Thiermann H Toxicology; 2008 Feb; 244(1):35-41. PubMed ID: 18054823 [TBL] [Abstract][Full Text] [Related]
14. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. Quistad GB; Klintenberg R; Casida JE Toxicol Sci; 2005 Aug; 86(2):291-9. PubMed ID: 15888665 [TBL] [Abstract][Full Text] [Related]
15. Research into selective biomarkers of erythrocyte exposure to organophosphorus compounds. Aminoff D; Bochar DA; Fuller AA; Mapp AK; Showalter HD; Kirchhoff PD Anal Biochem; 2009 Sep; 392(2):155-61. PubMed ID: 19497294 [TBL] [Abstract][Full Text] [Related]
16. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. Albuquerque EX; Pereira EF; Aracava Y; Fawcett WP; Oliveira M; Randall WR; Hamilton TA; Kan RK; Romano JA; Adler M Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13220-5. PubMed ID: 16914529 [TBL] [Abstract][Full Text] [Related]
17. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study. Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245 [TBL] [Abstract][Full Text] [Related]
18. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study. Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526 [TBL] [Abstract][Full Text] [Related]